Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study

被引:13
作者
Czarnecka, Karolina H. [1 ]
Migdalska-Sek, Monika [1 ]
Antczak, Adam [2 ]
Pastuszak-Lewandoska, Dorota [1 ]
Kordiak, Jacek [3 ]
Nawrot, Ewa [1 ]
Domanska, Daria [1 ]
Kaleta, Dorota [4 ]
Gorski, Pawe [5 ]
Brzezianska, Ewa Barbara [1 ]
机构
[1] Med Univ Lodz, Dept Mol Bases Med, PL-92213 Lodz, Poland
[2] Med Univ Lodz, Dept Gen & Oncol Pneumol, PL-90153 Lodz, Poland
[3] Med Univ Lodz, Dept Thorac Surg Gen & Oncol Surg, PL-90710 Lodz, Poland
[4] Med Univ Lodz, Dept Prevent Med, PL-90643 Lodz, Poland
[5] Med Univ Lodz, Dept Pneumol & Allergol, PL-90153 Lodz, Poland
关键词
Non-small cell lung carcinoma (NSCLC); Loss of heterozygosity (LOH); Microsatellite instability (MSI); Microsatellite markers; Genetic instability; TUMOR-SUPPRESSOR GENE; CHROMOSOMAL ALTERATIONS; PROGNOSTIC-SIGNIFICANCE; COPY NUMBER; CANCER; HETEROZYGOSITY; SMOKING; ADENOCARCINOMA; EXPRESSION; PATTERNS;
D O I
10.1007/s11033-013-2782-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In lung cancer pathogenesis, genetic instability, i.e., loss of heterozygosity (LOH) and microsatellite instability (MSI) is a frequent molecular event, occurring at an early stage of cancerogenesis. The presence of LOH/MSI in non-small cell lung carcinoma (NSCLC) was found in many chromosomal regions, but exclusive of 3p their diagnostic value remains controversial. In this study we focused on other than 3p regions-1p31.2, 7q32.2, 9p21.3, 11p15.5, 12q23.2 and 16q22-the loci of many oncogenes and tumour suppressor genes. To analyze the potential role of LOH/MSI involved in NSCLC pathogenesis we allelotyped a panel of 13 microsatellite markers in a group of 56 cancer specimens. Our data demonstrate the presence of allelic loss for all (13) analyzed markers. Total LOH/MSI frequency in NSCLC was the highest for chromosomal region 11p15.5 (25.84 %), followed by 9p21.3 and 1p31.2 (19.87 and 16.67 % respectively). A statistically significant increase of total LOH/MSI frequency was detected for the 11p15.5 region (p = 0.0301; chi(2) test). The associations of total LOH/MSI frequency: 1) increase in 11p15.5 region (p = 0.047; chi(2) test) and 2) decrease in 7q32.2 region (p = 0.037; chi(2) test) have been statistically significant in AJCC III (American Joint Committee on Cancer Staging). In Fractional Allele Loss (FAL) index analysis, the correlation with cigarette addiction has been statistically significant. The increased amount of cigarettes smoked (pack years) in a lifetime correlates with increasing FAL (p = 0.024; Kruskal-Wallis test). These results demonstrate that LOH/MSI alternation in studied chromosomal regions is strongly influenced by tobacco smoking but do not seem to be pivotal NSCLC diagnostic marker with prognostic impact.
引用
收藏
页码:6671 / 6684
页数:14
相关论文
共 37 条
  • [1] The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways
    Badgwell, D. B.
    Lu, Z.
    Le, K.
    Gao, F.
    Yang, M.
    Suh, G. K.
    Bao, J-J
    Das, P.
    Andreeff, M.
    Chen, W.
    Yu, Y.
    Ahmed, A. A.
    Liao, W. S-L
    Bast, R. C., Jr.
    [J]. ONCOGENE, 2012, 31 (01) : 68 - 79
  • [2] Chromosomal imbalances in human lung cancer
    Balsara, BR
    Testa, JR
    [J]. ONCOGENE, 2002, 21 (45) : 6877 - 6883
  • [3] Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer
    Bepler, G
    Gautam, A
    McIntyre, LM
    Beck, AF
    Chervinsky, DS
    Kim, YC
    Pitterle, DM
    Hyland, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1353 - 1360
  • [4] Cytogenetic findings in thirty lung carcinoma patients
    Berker-Karaüzüm, S
    Lüleci, G
    Özbilim, G
    Erdogan, A
    Kuzucu, A
    Demircan, A
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 100 (02) : 114 - 123
  • [5] High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer
    Bremnes, RM
    Veve, R
    Gabrielson, E
    Hirsch, FR
    Baron, A
    Bemis, L
    Gemmill, RM
    Drabkin, HA
    Franklin, WA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2417 - 2428
  • [6] Chmara M, 2004, ANTICANCER RES, V24, P4259
  • [7] Collins LG, 2007, AM FAM PHYSICIAN, V75, P56
  • [8] Czarnecka Karolina, 2011, Front Biosci (Elite Ed), V3, P137, DOI 10.2741/e228
  • [9] Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas
    Ding, Xiao-Jie
    Liu, Min-Xia
    Ao, Lei
    Liang, Yi-Rong
    Cao, Yi
    [J]. VIRCHOWS ARCHIV, 2011, 458 (05) : 561 - 569
  • [10] E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway
    Dong, Ling-ling
    Liu, Lian
    Ma, Chun-hong
    Li, Ji-sheng
    Du, Chao
    Xu, Shan
    Han, Li-hui
    Li, Li
    Wang, Xiu-wen
    [J]. ACTA PHARMACOLOGICA SINICA, 2012, 33 (06) : 817 - 822